John Nosenzo

Insider Reports History

Location
Durham, NC
Signature
/s/ Megan Smeykal, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Nosenzo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bioventus Inc. Fmr. Chief Commercial Officer Class A Common Stock 87,148 $360,688 $4.14 03 Oct 2022 Direct
TELA Bio, Inc. Director Common Stock 6,270 $35,422 $5.65 01 Jun 2023 Direct
TELA Bio, Inc. Director Stock Option (Right to Buy) 5,360 01 Jun 2023 Direct

Insider Reports Filed by John Nosenzo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TELA TELA Bio, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:36
TELA TELA Bio, Inc. 01 Jun 2022 2 $0 4 Director 02 Jun 2022, 16:07
BVS Bioventus Inc. 01 Apr 2022 3 -$1,251 4 Fmr. Chief Commercial Officer 21 Apr 2023, 17:45
BVS Bioventus Inc. 01 Apr 2022 3 -$733,502 4 Chief Commercial Officer 05 Apr 2022, 21:14
BVS Bioventus Inc. 11 Feb 2022 3 -$6,401 4 Chief Commercial Officer 15 Feb 2022, 20:17
BVS Bioventus Inc. 10 Feb 2022 3 +$311,760 4 CHIEF COMMERCIAL OFFICER 14 Feb 2022, 19:41
TELA TELA Bio, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:08
TELA TELA Bio, Inc. 02 Jun 2021 0 $0 3 Director 04 Jun 2021, 16:49